Lutonix

Lutonix

Verified
New drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$225m (Public information from Dec 2011)
Maple Grove Minnesota (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

$0.0

round
investor

$0.0

round
N/A

$0.0

round

$225m

Valuation: $225m

Acquisition
Total Funding000k

Recent News about Lutonix

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.